154 related articles for article (PubMed ID: 32319567)
41. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
[No Abstract] [Full Text] [Related]
43. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
Sasaki K; Kurahara H; Young ED; Natsugoe S; Ijichi A; Iwakuma T; Welch DR
Clin Exp Metastasis; 2017 Apr; 34(3-4):229-239. PubMed ID: 28289921
[TBL] [Abstract][Full Text] [Related]
44. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
45. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
47. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.
Owusu-Ansah KG; Song G; Chen R; Edoo MIA; Li J; Chen B; Wu J; Zhou L; Xie H; Jiang D; Zheng S
Int J Oncol; 2019 Aug; 55(2):391-404. PubMed ID: 31268154
[TBL] [Abstract][Full Text] [Related]
48. [Detection of chitinase 3-like 1 combined with other biomarkers for diagnosis of pancreatic cancer].
Ma YF; He LM; Wu Q; Ma YF; Wang XQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):450-454. PubMed ID: 29735446
[TBL] [Abstract][Full Text] [Related]
49. Establishment of an orthotopic model of pancreatic cancer to evaluate the antitumor effects of irinotecan through the biomarker carbohydrate antigen 19-9 in mice.
Li L; Yue GG; Fung KP; Leung PC; Lau CB; Leung PS
Pancreas; 2014 Oct; 43(7):1126-8. PubMed ID: 25207664
[No Abstract] [Full Text] [Related]
50. E-selectin binding by pancreatic tumor cells is inhibited by cancer sera.
Sawada T; Ho JJ; Chung YS; Sowa M; Kim YS
Int J Cancer; 1994 Jun; 57(6):901-7. PubMed ID: 7515860
[TBL] [Abstract][Full Text] [Related]
51. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice.
Armacki M; Polaschek S; Waldenmaier M; Morawe M; Ruhland C; Schmid R; Lechel A; Tharehalli U; Steup C; Bektas Y; Li H; Kraus JM; Kestler HA; Kruger S; Ormanns S; Walther P; Eiseler T; Seufferlein T
Gastroenterology; 2020 Sep; 159(3):1019-1035.e22. PubMed ID: 32446697
[TBL] [Abstract][Full Text] [Related]
52. Combined inhibition of PAK7, MAP3K7 and CK2alpha kinases inhibits the growth of MiaPaCa2 pancreatic cancer cell xenografts.
Giroux V; Iovanna JL; Garcia S; Dagorn JC
Cancer Gene Ther; 2009 Sep; 16(9):731-40. PubMed ID: 19363471
[TBL] [Abstract][Full Text] [Related]
53. MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer.
Wang L; Wang Z; Huang L; Wu C; Zhang B
Anticancer Drugs; 2019 Mar; 30(3):281-288. PubMed ID: 30601190
[TBL] [Abstract][Full Text] [Related]
54. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer.
Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L
Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874
[TBL] [Abstract][Full Text] [Related]
55. Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.
Tung CL; Lin MW; Hu RY; Chien YC; Liao EC; Lin LH; Chung TW; Wei YS; Tsai YT; Chen HY; Chou HC; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2020 Jul; 186():113300. PubMed ID: 32413824
[TBL] [Abstract][Full Text] [Related]
56. Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells.
Aubert M; Panicot L; Crotte C; Gibier P; Lombardo D; Sadoulet MO; Mas E
Cancer Res; 2000 Mar; 60(5):1449-56. PubMed ID: 10728712
[TBL] [Abstract][Full Text] [Related]
57. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract][Full Text] [Related]
58. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.
Martinez-Useros J; Li W; Georgiev-Hristov T; Fernandez-Aceñero MJ; Borrero-Palacios A; Perez N; Celdran A; Garcia-Foncillas J
Pathol Oncol Res; 2019 Jan; 25(1):269-278. PubMed ID: 29101736
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma.
Takahashi S; Oda T; Hasebe T; Sasaki S; Kinoshita T; Konishi M; Ueda T; Nakahashi C; Ochiai T; Ochiai A
Pathobiology; 2001; 69(3):127-35. PubMed ID: 11872958
[TBL] [Abstract][Full Text] [Related]
60. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
